Side-effect support: Fast access to clinicians via live chat or the hotline for tailored advice and, where appropriate, short-term symptom relief if needed (for example, anti-nausea tablets)
Answers to these questions may help guide obesity treatment, but may also inform future areas of research as we learn more about the beneficial effects of GLP-1 receptor agonists such as semaglutide, Ortiz-Pujols said
60 Additionally, there were no statistically significant differences in glycemic control between the two medications, and neither demonstrated significant benefits for liver fibrosis
We put our clients first in every aspect of our representation by seeking to understand their lived experiences and crafting a legal strategy that can lead to compensation
Ozempic and Wegovy risks: what physicians are noticing The potential risk for muscle loss from GLP-1 therapies is significant enough that many clinicians are in favor of cautionary steps around prescribing and monitoring